You are here

Sanofi

Latecomer Sanofi looks to catch next wave of cancer therapies

Latecomer Sanofi looks to catch next wave of cancer therapies

Reuters

immuno-oncology

Flag link:

Evotec seals deal for Sanofi’s infectious disease unit

Evotec seals deal for Sanofi’s infectious disease unit

Fierce Biotech

infectious diseases

Flag link:

Study confirms higher risk of dengue in kids who got Sanofi vaccine

Study confirms higher risk of dengue in kids who got Sanofi vaccine

Reuters

Flag link:

Can Sanofi compete in lung cancer? With I-O med cemiplumab, it’s aiming for third

Can Sanofi compete in lung cancer? With I-O med cemiplumab, it’s aiming for third

Fierce Pharma

PD-1 inhibitors

Flag link:

Sanofi says on track to regain solid position in cancer drugs

Sanofi says on track to regain solid position in cancer drugs

Reuters

molecular oncology

Flag link:

GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report

GlaxoSmithKline to pass $10B in 2024 vaccine sales, with Merck, Sanofi and Pfizer rounding out the top 4: report

Fierce Pharma

Flag link:

With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines

With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines

Xconomy

Flag link:

Citing 'substantial benefit' for patients, Sanofi hiked Flublok price 12.5% last season

Citing 'substantial benefit' for patients, Sanofi hiked Flublok price 12.5% last season

Fierce Pharma

Flag link:

Want to score on social, pharma? Follow Sanofi's lead, experts say

Want to score on social, pharma? Follow Sanofi's lead, experts say

Fierce Pharma

Flag link:

Sanofi tweaks pricing policies, discloses 8.4% net price decline in 2017

Sanofi tweaks pricing policies, discloses 8.4% net price decline in 2017

Fierce Pharma

Flag link:

Ambien maker trolls Roseanne Barr: 'Racism is not a known side effect of any Sanofi medication'

Ambien maker trolls Roseanne Barr: 'Racism is not a known side effect of any Sanofi medication'

CNBC

Flag link:

Here’s how Sanofi separates true innovation from all the hype in digital health

Here’s how Sanofi separates true innovation from all the hype in digital health

Drug Delivery Business News

Flag link:

Sanofi’s shift to robots and ‘digital twins’ at U.S. biologics site costs 95 jobs

Sanofi’s shift to robots and ‘digital twins’ at U.S. biologics site costs 95 jobs

Fierce Pharma

drug manufacturing

Flag link:

Are These Disappointing Drugs Back on Track to Billions?

Are These Disappointing Drugs Back on Track to Billions?

Motley Fool

PCSK9 inhibitors

Flag link:

3 Reasons Regeneron Stock Could Start Climbing Again

3 Reasons Regeneron Stock Could Start Climbing Again

Yahoo/Motley Fool

Flag link:

Lilly, Pfizer, Sanofi lead in patent litigation, report says

Lilly, Pfizer, Sanofi lead in patent litigation, report says

Biopharma Dive

patent lawsuits

Flag link:

Express Scripts Picks Regeneron Over Amgen, Cuts Heart Drug Price

Express Scripts Picks Regeneron Over Amgen, Cuts Heart Drug Price

Xconomy

Express Scripts

Flag link:

Regeneron/Sanofi circle October 28 on the calendar as the FDA begins a speedy review of the world’s 6th PD-1/L1 checkpoint

Regeneron/Sanofi circle October 28 on the calendar as the FDA begins a speedy review of the world’s 6th PD-1/L1 checkpoint

Endpoints

PD-1 inhibitors

Flag link:

4 Huge Pharma Deals in 4 Months Is Just the Beginning

4 Huge Pharma Deals in 4 Months Is Just the Beginning

Motley Fool

Juno Therapeutics

Flag link:

GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out

GI toxicity hits midstage Sanofi GLP-1 drug as patients drop out

Fierce Biotech

clinical trials

Flag link:

Pages